Lunsumio Velo 5 mg/.5mL
Mosunetuzumab · INJECTION · Genentech, Inc.
No Recall History
Plain English
Lunsumio Velo is a injection containing mosunetuzumab at 5 mg/.5mL, taken subcutaneous. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- Lunsumio Velo
- Generic Name
- Mosunetuzumab
- NDC Code (Product)
50242-177- Manufacturer
- Genentech, Inc.
- Strength
- 5 mg/.5mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761263
- Marketing Start
- 12/19/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Lunsumio Velo used for?
Lunsumio Velo contains Mosunetuzumab. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is Lunsumio Velo a controlled substance?
Lunsumio Velo is not classified as a controlled substance by the DEA.
What is the generic name for Lunsumio Velo?
The generic name for Lunsumio Velo is Mosunetuzumab. There are 2 other brand versions of Mosunetuzumab.
What is the NDC code for Lunsumio Velo 5 mg/.5mL?
The NDC (National Drug Code) for Lunsumio Velo 5 mg/.5mL is 50242-177, listed by Genentech, Inc..